Vertex Pharmaceuticals | VRTX - Ebitda





Ebitda Alterar Data
AbbVie USD 6.91B 3.22B 2026-06
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 3.86B 1.28B 2026-03
Arrowhead Research USD -147.68M 40.33M 2026-06
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.99B 721M 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06